Wigraine - Drug Details
📊 Estimates Wigraine Dialyzability By Different_Modalities

Wigraine

Complete Drug Information

Drug Name
Wigraine
Pregnancy Category
AU: A
Bioavailability
99%
Routes of Administration
Common:Oral Medical: Intravenous Uncommon: Insufflation, rectal, transdermal, topical, buccal, sublingual
Protein Binding
10–36%%
Metabolism
Primary: CYP1A2Minor: CYP2E1, CYP3A4,CYP2C8, CYP2C9
Elimination
Adults: 3–7 hoursInfants (full term): 8 hoursInfants (premature): 100 hours
Excretion
Urine (100%)
Formula
C8H10N4O2
Molar Mass
194.194
Onset of Action
45 minutes–1 hour
Duration of Action
3–4 hours
Melting Point
235 to 238 °C
Drug Class
Stimulant;Adenosinergic; Eugeroic;Nootropic;Anxiogenic; Analeptic; PDE inhibitor;Diuretic
Volume of Distribution
C8H10N4O2

🤰 Pregnancy Category Information

Category: AU: A

Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus.